Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Rosalia, R.A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(10)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(10)
+
-
Creation Date
2015
(4)
+
-
2012
(3)
+
-
2013
(2)
+
-
2014
(2)
+
-
Faculty
Faculty of Science
(2)
+
-
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Leiden Academic Centre for Drug Research (LACDR)
(2)
+
-
Topic
PLGA
(4)
+
-
Dendritic cells
(3)
+
-
Immunotherapy
(2)
+
-
Nanoparticles
(2)
+
-
Targeting
(2)
+
-
Author
Rosalia, R.A.
(11)
+
-
Ossendorp, F.
(9)
+
-
Jiskoot, W.
(7)
+
-
Oostendorp, J.
(7)
+
-
Silva, A.L.
(7)
+
-
Burg, S.H. van der
(5)
+
-
Cruz, L.J.
(4)
+
-
Khan, S.
(3)
+
-
Melief, C.J.M.
(3)
+
-
Quakkelaar, E.D.
(3)
+
-
Camps, M.
(2)
+
-
Duikeren, S. van
(2)
+
-
Gruijl, T. de
(2)
+
-
Sibuea, S.
(2)
+
-
Tromp, A.T.
(2)
+
-
Varypataki, E.
(2)
+
-
Show more
Language
en
(11)
+
-
Search results
(1 - 11 of 11)
show grid
show list
save search
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation
Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: A comparative study
Particulate based vaccines for cancer immunotherapy
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles
Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8(+) T cell activation
Mechanism of superior cross-presentation of synthetic long peptides in comparison with protein for therapeutic cancer vaccination
Mechanism of superior cross-presentation of synthetic long peptides in comparison with protein for therapeutic cancer vaccination